WASHINGTON U.S. President Donald Trump on Thursday thanked two major drug companies for not raising their prices and said his administration was working toward "substantially" cutting prescription-drug prices.
- Chinese pharma firm recalls heart drug in U.S. after possible impurity
- Pharmacy technician charged in case tied to U.S. meningitis outbreak
- Roche takes Tecentriq hit on survival data
- Allergan, Molecular Partners eye drug meets main goal in two studies
- Bulgaria reports another case of ovine rinderpest
ZURICH Novartis said on Thursday it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology.
Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after a patient's death was possibly linked to the treatment.
(Reuters Health) - High school students in the U.S. are a lot more sober than they used to be, a new study suggests.
WASHINGTON AngioDynamics Inc has agreed to pay the U.S. government $12.5 million to resolve allegations it caused healthcare providers to submit false claims to federal healthcare programs over the use of two medical devices, the Justice Department said on Wednesday.